News for Cipher Pharmaceuticals Inc. (PHE.F)

NeonMind Biosciences Inc. is pleased to announce that it has filed four new provisional patent applications with the United States Patent and Trademark Office to protect initial data obtained... | March 2, 2021

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Moderate-to-Severe

OAKVILLE, ON, Feb. 10, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced it has entered into an ...